Pretreatment of IFNγ was noticed to enhance ferroptosis induced by erastin and RSL3 in HCC cells, with increased accumulation of ROS which could be reversed by ferrostatin-1 (Kong et al., 2021). This evidence concerns the gene IFNG and hepatocellular carcinoma.